Does Metformin Really Cause Hot Flashes?

Metformin is not established as a cause of hot flashes. No large clinical study lists hot flashes among its common or even uncommon side effects. In fact, the limited clinical data that directly links metformin to hot flashes actually points in the opposite direction: a published case series found metformin relieved hot flashes in all three patients treated. The question, though, touches on something genuinely complicated, because metformin interacts with several biological systems that do influence body temperature, hormone levels, and blood-vessel behavior.

What the Clinical Evidence Actually Shows

The most direct clinical evidence connecting metformin to hot flashes comes from a small but striking case series published in Endocrine Practice. Three patients who had been suffering from long-standing hot flashes, excessive sweating, and fatigue were started on metformin at 500 mg twice daily. All three experienced marked relief of their symptoms.¹ These patients were not on metformin for diabetes in the usual sense. Their workups pointed to hyperinsulinemia as the culprit behind the hot flashes, and metformin, by lowering insulin levels, calmed the symptoms down.

This is a small case series, not a large randomized trial, so it does not prove that metformin will help everyone with hot flashes. But it is the only published clinical report directly examining the metformin-hot-flash relationship, and it found the drug helped rather than hurt. That matters, because people who Google “metformin hot flashes” are often looking for confirmation that metformin is causing a new symptom. The published evidence, limited as it is, does not support that assumption.

Why Hot Flashes and Metformin Often Show Up Together

If metformin does not appear to cause hot flashes, why do so many people notice them after starting the drug? The simplest explanation is timing. Metformin is the most widely prescribed medication for type 2 diabetes, and type 2 diabetes is most commonly diagnosed in middle-aged and older adults. In women, that overlaps squarely with perimenopause and menopause, the life stage when hot flashes are most common for reasons entirely unrelated to metformin. A woman who starts metformin at 50 and then begins having hot flashes at 51 may understandably suspect the drug, but the far more likely explanation is declining estrogen.

Diabetes itself also plays a role. People with type 2 diabetes often have higher circulating insulin levels, especially early in the disease, and the autonomic nervous system disturbances that come with diabetes can produce sweating, flushing, and temperature instability on their own. These symptoms look and feel like hot flashes but stem from the metabolic condition, not from the pill being used to treat it. Teasing apart what is caused by the disease, what is caused by the treatment, and what is caused by age-related hormonal shifts is genuinely difficult without careful clinical evaluation.

The Hyperinsulinemia Connection

The case series described above proposed a specific mechanism worth understanding. High insulin levels in the blood, even when blood sugar stays normal, can rev up the sympathetic nervous system. That is the “fight or flight” branch of your nervous system, the one that triggers sweating, flushing, and a racing heartbeat. The researchers proposed that this sympathetic overdrive from hyperinsulinemia was producing the hot flashes in their patients.¹

Metformin works in part by improving insulin sensitivity, which means the body needs less insulin to do the same job. As insulin levels drop, the sympathetic overdrive calms down, and the flushing goes with it. In this model, metformin is not a cause of hot flashes but a treatment for one particular kind of hot flash, the type driven by too much insulin. This distinction gets lost when people report side effects without distinguishing between the drug’s effects and the effects of the underlying condition the drug is treating.

Could Metformin Lower Estrogen Enough to Trigger Flashes?

There is a theoretical pathway by which metformin could contribute to hot flashes, though no clinical study has demonstrated it happening in practice. Metformin has been shown in laboratory studies to inhibit aromatase, the enzyme responsible for converting other hormones into estrogen. Researchers have found that metformin significantly decreased aromatase expression in human breast adipose stromal cells at concentrations as low as 10 micromolar.² Separate work in human granulosa cells confirmed that metformin significantly reduced both aromatase gene expression and enzyme activity.³

Since hot flashes in menopausal women are driven primarily by falling estrogen levels, a drug that further suppresses estrogen production could theoretically make flashes worse. This is exactly what happens with aromatase inhibitor drugs used in breast cancer treatment, where hot flashes are one of the most common complaints. However, there is an important difference of scale. The aromatase-inhibiting effect of metformin in these studies was observed in isolated cells under controlled conditions, and the concentrations involved are far below those achieved with dedicated aromatase inhibitor drugs. Additional work showed that metformin’s inhibition of aromatase was promoter-specific, meaning it selectively affected certain tissue contexts rather than producing a blanket estrogen shutdown across the body.⁴

So while the aromatase mechanism is real and interesting, especially in oncology research, no clinical trial has shown that metformin at standard doses produces enough estrogen suppression to trigger or worsen hot flashes in living humans. This is where the evidence gets thin. The lab results are consistent and reproducible, but nobody has yet demonstrated the downstream clinical effect in patients. If you are already in late perimenopause or menopause and your estrogen levels are hovering near the threshold where flashes start, even a small additional dip could matter. But that remains speculation, not established fact.

Metformin and Heat Production

A different line of research shows that metformin can activate thermogenesis, the process by which the body generates heat, in brown fat tissue. In a study on mice, metformin enhanced markers associated with heat production in brown fat through adrenergic stimulation and a signaling molecule called fibroblast growth factor 21.⁵ The drug also appeared to improve mitochondrial activity and fat breakdown within this tissue.

Brown fat is one of the body’s built-in furnaces. When it is activated, it burns calories to produce warmth. Whether this translates into noticeable warmth or flushing in people taking standard metformin doses is unknown. Humans have much less brown fat than mice, and the effect observed in the study was in isolated brown fat cells, not whole animals walking around and reporting how they felt. Still, for someone looking for biological plausibility that metformin could make them feel warmer, this is a real mechanism. It just has not been confirmed as clinically meaningful in humans.

Thyroid Function and Metformin

Hot flashes can also be a symptom of thyroid overactivity, and metformin has been shown to affect thyroid hormones in animal studies. Male rats given metformin showed significant increases in free T3 and free T4, the active thyroid hormones, along with a slight but significant drop in TSH. The rats also displayed irritability and diarrhea, symptoms consistent with hyperthyroidism.⁶ This effect occurred whether or not the rats had diabetes.

In humans, the relationship between metformin and thyroid function is more nuanced and the findings less dramatic. Clinical studies in people have generally shown metformin can lower TSH levels, particularly in patients with hypothyroidism who are already on thyroid replacement medication. But the kind of overt hyperthyroid-like state seen in the rat study has not been widely reported in human patients on metformin. The relevance here is that if you start metformin and develop symptoms like heat intolerance, sweating, and a racing heart, it is worth checking thyroid function, because metformin might nudge thyroid hormone levels in a direction that contributes to those symptoms in susceptible individuals.

Vascular Effects That Mimic Flushing

Flushing, the sudden reddening and warming of the skin, involves changes in blood vessel tone. An animal study looking at the immediate vascular effects of both insulin and metformin found that both substances caused significant constriction of peripheral resistance arteries in anesthetized pigs.⁷ This is somewhat counterintuitive, since hot flashes involve vasodilation, not constriction. But vascular tone is dynamic: a period of constriction can be followed by a rebound dilation, and the autonomic adjustments the body makes in response to changing blood flow patterns can produce sensations of warmth, tingling, or flushing.

This vascular effect is another piece of indirect evidence. It shows metformin is doing something to blood vessels, and that something could, under certain circumstances, produce sensations that feel like a hot flash. But “could produce” and “does produce” are separated by a gap that no clinical trial has bridged.

Vitamin B12 Depletion and Symptom Confusion

One well-documented side effect of long-term metformin use is vitamin B12 deficiency. Over the past two decades, evidence has accumulated that metformin interferes with B12 absorption in the gut, and many studies have confirmed higher rates of B12 deficiency among metformin-treated patients with type 2 diabetes.⁸

Vitamin B12 deficiency does not directly cause hot flashes, but its symptoms can overlap with and amplify the experience. B12 deficiency can cause peripheral neuropathy, meaning tingling, burning, and abnormal sensations in the extremities. It can cause fatigue and mood changes. For someone who is also experiencing hot flashes from menopause or hyperinsulinemia, the added burden of B12-related nerve symptoms can make the overall experience feel worse or more disorienting. A person might describe the burning nerve sensations in their hands and feet as part of their “hot flash” experience, when in reality they have two separate problems. If you have been on metformin for several years and your symptoms seem to be getting more complex or harder to explain, B12 levels are worth checking.

When the Real Culprit Is the Condition, Not the Drug

Type 2 diabetes and insulin resistance themselves cause autonomic nervous system dysfunction. The autonomic nervous system controls sweating, blood-vessel diameter, and temperature regulation. When it is not working properly, you get unpredictable sweating, sudden warmth, and flushing episodes that look a lot like hot flashes. This is called autonomic neuropathy, and it is common in diabetes, especially when blood sugar has been poorly controlled for years.

This creates a frustrating diagnostic loop. You have diabetes. You take metformin. You get hot flashes. You blame metformin. But the hot flashes may actually be caused by the same insulin resistance and autonomic damage that made you need metformin in the first place. The case series mentioned earlier illustrated exactly this pattern: the hot flashes were being driven by hyperinsulinemia, and metformin was the solution, not the problem.

If you are trying to figure out whether metformin is behind your hot flashes, the honest answer is that no published evidence supports it as a common cause. The far more likely explanations are hormonal changes related to age, autonomic effects of diabetes itself, or other medications you may be taking alongside metformin. That said, the theoretical pathways through estrogen modulation, thermogenesis, and thyroid effects mean the question is not absurd. It is just not answered in your favor if you are hoping to find metformin listed as the villain.

Practical Steps If You Suspect Metformin

If you have started or changed your metformin dose and noticed new or worsening hot flashes, a few practical steps can help clarify what is going on:

Check your timing: Did the hot flashes truly start after metformin, or were they creeping in beforehand? Perimenopause symptoms can develop gradually over months, and the brain is very good at finding false cause-and-effect connections.
Get your hormones checked: A blood test measuring estradiol, FSH, and thyroid hormones can quickly sort out whether menopause, thyroid dysfunction, or both are contributing.
Check B12 and fasting insulin: If you have been on metformin for more than a year, B12 testing is reasonable. If your flushing episodes are accompanied by sweating and fatigue, fasting insulin levels can reveal whether hyperinsulinemia is part of the picture.
Review other medications: Many drugs taken alongside metformin are known to cause hot flashes. Certain blood pressure medications, antidepressants, and opioids are all more strongly linked to flushing than metformin is.

Stopping metformin to test whether it is causing your hot flashes is generally not advisable without medical guidance, since uncontrolled blood sugar carries its own risks. A more measured approach is to work with your doctor to rule out the more common explanations first.

Metformin’s Emerging Reputation Beyond Diabetes

Part of the reason the metformin-hot-flash question draws so much interest is that metformin has become something of a celebrity drug. It is being studied for potential anti-aging effects, cancer prevention, and metabolic benefits well beyond glucose control. As more people take it, and as more people take it for reasons beyond straightforward diabetes management, the range of reported experiences widens. People taking metformin as part of a polycystic ovary syndrome treatment plan, for example, are generally younger and premenopausal, and they bring a different hormonal context to the table than a 60-year-old with type 2 diabetes.

The aromatase-inhibiting properties of metformin are particularly interesting in this context. Researchers studying breast cancer have been intrigued by metformin’s ability to reduce local estrogen production in breast tissue, since estrogen fuels many breast cancers. The hope is that metformin could complement existing cancer treatments by adding a mild anti-estrogenic effect in the right tissue at the right time. Whether this tissue-selective estrogen suppression ever becomes noticeable to the person taking the drug in the form of hot flashes remains an open question, but it is the kind of question that will likely be answered as metformin’s use in oncology and metabolic medicine continues to expand.